Oncologist, Gastroenterologist
Dr. Domenico Sabia is an experienced surgeon. He specializes in peritoneal oncology, melanoma and sarcoma surgery, laparoscopic and robotic surgery, and hepato-biliary and pancreatic surgery. He practices at Centro Médico Teknon and Consorci Sanitari Integral in Spain. Dr. Sabia has over 15 years of experience in treating advanced abdominal and pelvic cancers.
Dr. Sabia often speaks at national and international congresses. He has written and co-written many scientific publications. He also works as an investigator in major clinical trials in oncological surgery. He is accredited by organizations such as the Asociación Española de Cirujanos and The Peritoneal Surface Oncology Group International. Dr. Sabia is also a member of several respected surgical societies.
Dr. Lana Bijelic is a board-certified oncological surgeon. She specializes in peritoneal carcinomatosis. Since 2019, she has been part of the Carcinomatosis Surgical Group at the Teknon Oncology Institute. She trained under Prof. Paul Sugarbaker at Washington Hospital Center and brings strong expertise to her team.
Dr. Bijelic has worked as Research Director at Inova Fairfax Hospital. She has also been an associate professor at Virginia Commonwealth University and Georgetown University. She is an active member of the American College of Surgeons and the Society of Surgical Oncology.
Throughout her career, Dr. Bijelic has received many academic awards, including several Surgical Excellence Awards and top prizes in research. She is known for her leadership and important contributions to surgical oncology.
Dr. Michael Shapira is a specialist in Bone Marrow Transplantation with over 20 years of experience. He graduated from the Hebrew University Medical School in 1999. He completed his training in internal medicine at Hadassah Medical Center.
Dr. Shapira is a senior physician in the Bone Marrow Transplantation department at Hadassah. He has played a key role in many successful transplants and has helped maintain high patient survival rates. He is known for his clinical skills and commitment to improving transplantation medicine.
Dr. Dror Levin is a senior pediatrician and director of the blood disorder and bone cancer (sarcoma) treatment departments at Children's Hospital "Dana" and Medical Center "Sourasky" respectively. He is a specialist in pediatric medicine, hematology, and oncology, with additional experience studying abroad at the Rizzoli Orthopaedic Institute in Italy.
Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.
Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.
Professor of oncosurgery and proctology
Professor Dan Grisaro is a leading Israeli specialist in gynecological cancer diagnosis and treatment, specializing in ovarian cancer, uterine cancer, and cervical cancer. He has senior physician, head of department and lecturer experience at various medical centers and universities. He has held 39 presentations and is the author of 83 published scientific articles, and is a member of various professional societies.
Prof. Haim Matskin is a renowned specialist in onco-urology, urology, and surgery, and heads the Urology Department at Sourasky Medical Center. He is an expert in brachytherapy and cryotherapy and is a full-fledged member of the Medical Association of Israel and the Association of urologists of Europe, the US, and Israel.
Univ.-Prof. Dr. Wolfgang Johannes Köstler is a board-certified specialist for Internal Medicine, Hematology/Oncology, and Intensive Care Medicine who specializes in hematology & internal oncology, intensive care medicine. He is one of the top-rated breast cancer and sarcoma oncologist specialists and has extensive experience in the field and has received degrees from the Medical University of Vienna and the Weizmann Institute of Science. He has also had special training at Memorial Sloan-Kettering Cancer Center and Royal Prince Alfred Hospital.
Affrontare il cancro gastrointestinale e polmonare senza chemioterapia. Gli specialisti della Clinica Tel Aviv Sourasky (Ichilov) utilizzano un metodo innovativo ultra-moderno per combattere i tumori neuroendocrini. Si basa sulla terapia con radionuclidi con il radioisotopo Lutezio 177 (Lutezio-177). Questa innovazione è una vera svolta nell'oncoterapia, poiché negli ultimi decenni il numero di casi di questo tipo di cancro è aumentato rapidamente.
Questo metodo è completamente nuovo nel mondo. Oggi esiste solo in Israele, in Germania e in Svezia.
La sua essenza risiede nell'uso di un nuovo radiofarmaco - Lutezio 177 PRRT. Il farmaco viene somministrato per via endovenosa a intervalli di 7-8 settimane. Con l'aiuto del Lutezio, le cellule cancerose vengono distrutte selettivamente, senza influenzare i tessuti sani del corpo. Vale a dire, questo metodo di trattamento può letteralmente essere chiamato "terapia di radiazione locale". Inoltre, il farmaco non ha effetti tossici sul midollo osseo e sui reni, distruggendo il tumore dall'interno.
Inoltre, l'uso di questo metodo consente ai pazienti di evitare gli effetti collaterali gravi della chemioterapia, come vomito, nausea, dolore, alopecia, debolezza. È anche importante che il trattamento venga effettuato da un gruppo speciale di esperti medici. Tra di loro: medici leader, infermiere e fisici medici!
Tutti loro lavorano sotto la supervisione della Dott.ssa Inna Ospovat, specialista di punta del reparto di terapia nucleare della Clinica Ichilov.
Istruzione
2000-1994 Facoltà di Medicina a Vitebsk, Bielorussia.
Specializzazione
2003 - 2011 - specializzazione in oncologia e radioterapia presso l'Ospedale Universitario Hadassah a Gerusalemme.
Esperienza riconosciuta
Oncologia e radioterapia
Istruzione aggiuntiva
2015 - Ospedale Universitario PMH (Toronto) Irradiazione infantile e tumori della testa e del collo
Partecipazione a conferenze
Circa 10 presentazioni a conferenze mediche
Adesione ai sindacati
Eli Shpreher is a Head of the Department of Dermatology, Ichilov Medical Center - Sourasky.
Oncologist, specialist in gastrointestinal cancer treatment
Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.
She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.